Evidence map›Paper›PMID 25781651›Full record

ArticleGene therapy2015

Gene delivery to the spinal cord using MRI-guided focused ultrasound.

D Weber-Adrian, E Thévenot, M A O'Reilly, W Oakden, M K Akens, N Ellens, K Markham-Coultes, A Burgess, J Finkelstein, A J M Yee and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Gene therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 92 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Simultaneous proton resonance frequency TMagnetic resonance in medicine · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

D Weber-Adrian1] Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada [2] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
E Thévenot1] Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada [2] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
M A O'ReillyDepartment of Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
W Oakden1] Department of Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada [2] Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
M K Akens1] TECHNA Institute, University Health Network, Toronto, Ontario, Canada [2] Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
N Ellens1] Department of Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada [2] Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
K Markham-CoultesBiological Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
A BurgessDepartment of Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
J Finkelstein1] Department of Surgery, University of Toronto, Toronto, Ontario, Canada [2] Centre for Spinal Trauma, Division of Orthopaedic Surgery, Sunnybrook Research Institute, Toronto, Ontario, Canada.
A J M Yee1] Department of Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada [2] Department of Surgery, University of Toronto, Toronto, Ontario, Canada [3] Centre for Spinal Trauma, Division of Orthopaedic Surgery, Sunnybrook Research Institute, Toronto, Ontario, Canada.
C M Whyne1] Department of Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada [2] Department of Surgery, University of Toronto, Toronto, Ontario, Canada [3] Centre for Spinal Trauma, Division of Orthopaedic Surgery, Sunnybrook Research Institute, Toronto, Ontario, Canada.
K D FoustDepartment of Neuroscience, Ohio State University and Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
B K KasparDepartment of Neuroscience, Ohio State University and Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
G J Stanisz1] Department of Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada [2] Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
R ChopraDepartment of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
K Hynynen1] Department of Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada [2] Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
I Aubert1] Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada [2] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Sunnybrook Research InstituteNationwide Children's Hospital · USThe University of Texas Southwestern Medical Center · US

Funding

Ultrasound Therapy Delivery Through Intact SkullR01EB003268 · NIBIB · SUNNYBROOK & WOMEN'S COLL HLTH SCIS CTR · PI HYNYNEN, KULLERVO · 2003 to 2020
$8.2M
Canadian Institutes of Health Research FRN 93603NIBIB NIH HHS R01 EB003268NIBIB NIH HHS R01-EB003268
6 · The paper itself

Abstract

Non-invasive gene delivery across the blood-spinal cord barrier (BSCB) remains a challenge for treatment of spinal cord injury and disease. Here, we demonstrate the use of magnetic resonance image-guided focused ultrasound (MRIgFUS) to mediate non-surgical gene delivery to the spinal cord using self-complementary adeno-associated virus serotype 9 (scAAV9). scAAV9 encoding green fluorescent protein (GFP) was injected intravenously in rats at three dosages: 4 × 10(8), 2 × 10(9) and 7 × 10(9) vector genomes per gram (VG g(-1)). MRIgFUS allowed for transient, targeted permeabilization of the BSCB through the interaction of focused ultrasound (FUS) with systemically injected Definity lipid-shelled microbubbles. Viral delivery at 2 × 10(9) and 7 × 10(9) VG g(-1) leads to robust GFP expression in FUS-targeted regions of the spinal cord. At a dose of 2 × 10(9) VG g(-1), GFP expression was found in 36% of oligodendrocytes, and in 87% of neurons in FUS-treated areas. FUS applications to the spinal cord could address a long-term goal of gene therapy: delivering vectors from the circulation to diseased areas in a non-invasive manner.

Indexed as

Genetic TherapyAnimalsDependovirusGreen Fluorescent ProteinsMagnetic Resonance ImagingMaleNeuronsOligodendrogliaRats, WistarSpinal CordSpinal Cord DiseasesUltrasonographyGreen Fluorescent Proteins

Identifiers

PMID25781651
PMCPMC4490035
OpenAlexW2082319347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.